Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Find out ...

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.

WD-40 beats Q2 revenue & EPS estimates, guides 2026 growth, but valuation looks rich vs peers. Read more here.

Florida football head coach Jon Sumrall spoke with the sports media on Tuesday. Here's everything he said during that ...

The S&P 500 (^GSPC) and the tech-heavy Nasdaq Composite (^IXIC) gained 0.6% and 0.8%, respectively, extending their daily ...

PLTR stock analysis: How Palantir moved from a 2020 direct listing to an AI bellwether - GAAP profitability, AIP bootcamps, ...

Beyond the war, CoreWeave stock rocketed 13% higher after the company announced it is entering a multiyear agreement with ...

Boris Cherny, the head of Claude Code, almost parted ways with Anthropic for good last summer. Instead, he has helped shape ...

Now working under a four-year deal rather than three, the writers got some much-needed healthcare relief, along with added residuals and protections.

Amneal Pharmaceuticals AMRX enters 2026 with multiple levers working at once. Fiscal 2025 delivered broad-based revenue gains ...

Binance just deployed a new volatility shield called PRER that blocks spot orders from filling at abnormal prices, going live April 14 per NewsBTC. That keeps ...

The chronology explains the confidence shock. On 2 April 2026, NDB disclosed an internal fraud incident with an initial impact estimate of about Rs.380 million and ..